Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Potent GCN2 Inhibitor Capable of Reversing MDSC-Driven T Cell Suppression Demonstrates In Vivo Efficacy as a Single Agent and in Combination with Anti-Angiogenesis Therapy.
Journal: Journal of medicinal chemistry
Published: September 20, 2022
Imidazo[1,2-a]pyridin-6-yl-benzamide analogs as potent RAF inhibitors.
Journal: Bioorganic & medicinal chemistry letters
Published: August 01, 2017
Discovery of RAF265: A Potent mut-B-RAF Inhibitor for the Treatment of Metastatic Melanoma.
Journal: ACS medicinal chemistry letters
Published: December 19, 2014
Correction to Design and Synthesis of Orally Bioavailable Benzimidazole Reverse Amides as Pan RAF Kinase Inhibitors.
Journal: ACS medicinal chemistry letters
Published: December 18, 2014
Design, structure-activity relationship, and in vivo characterization of the development candidate NVP-HSP990.
Journal: Journal of medicinal chemistry
Published: November 05, 2014
Design and Synthesis of Orally Bioavailable Benzimidazole Reverse Amides as Pan RAF Kinase Inhibitors.
Journal: ACS medicinal chemistry letters
Published: April 23, 2014
Showing 1-6 of 6
Last Updated: 09/26/2026